The immune system provides different mechanisms to protect organisms against pathogens, most of which are infectious agents. Simultaneously, immune activation secondary to genetic factors and/or environmental signals can induce detrimental autoimmunity. The effector pathways in host defense and autoimmunity use similar cytokines and chemokines. Accordingly, tumor necrosis factor alpha (TNF-␣), for instance, is similarly important in the control of various infections and in the induction of autoimmunity.
The immune system provides different mechanisms to protect organisms against pathogens, most of which are infectious agents. Simultaneously, immune activation secondary to genetic factors and/or environmental signals can induce detrimental autoimmunity. The effector pathways in host defense and autoimmunity use similar cytokines and chemokines. Accordingly, tumor necrosis factor alpha (TNF-␣), for instance, is similarly important in the control of various infections and in the induction of autoimmunity.
Hallmarks of the adaptive immune system are antigen-specific cellular and humoral immune responses. Secondary lymphoid organs serve as sites of contact between antigen-presenting cells (APCs) and immune effector T and B lymphocytes. Chemokines and cytokines serve as messengers determining the type of immune response to a given antigen. The TNF family cytokine lymphotoxin (LT) plays a pivotal role in the development of secondary lymphoid organs.
The chronic and relapsing course of many autoimmune diseases calls for new biological agents capable of suppressing the underlying inflammatory disorders. Recent studies indicate that inhibition of LT␤ receptor (LT␤R)-mediated signaling in adult animals suppresses autoimmunity by modulating the cellular structure of secondary lymphoid organs (reviewed in ref- erence 22) . Because of the wide range of autoimmune diseases positively influenced by this treatment, blockade of the LT␤R might serve as a new treatment principle for human autoimmune diseases. However, immune responses to infectious pathogens are also altered in mice with disrupted LT␤R signaling. While the course of virus-and lipopolysaccharide (LPS)-induced shock, experimental Trypanosoma brucei infection, cerebral malaria, and experimental prion disease are less severe, inhibition of the LT␤R is also associated with exacerbation of mycobacterial infection and infectious colitis. This review summarizes the findings of studies using mice with disrupted LT␤R signaling in models of infectious diseases and discusses the relevance of these observations in considering LT␤R blockade as a potential treatment for human autoimmune diseases.
THE LYMPHOTOXIN AND LIGHT LIGAND/RECEPTOR SYSTEM AND ITS ROLE IN LYMPHOID ORGAN ARCHITECTURE AND AUTOIMMUNE DISEASES
Expression and regulation of ligands and receptors. Lymphotoxin is a TNF family cytokine. The seminal discovery of impaired secondary lymphoid organ formation in LT␣ genedeficient (Ϫ/Ϫ) mice (11) has shed new light on the biological functions of LT, which was long considered to be a redundant cytokine for TNF-␣. Figure 1 , top left, describes the LT/ LIGHT ligands and receptors. Soluble LT␣ 3 is a secreted protein that interacts with the TNF receptors I (55 kDa) and II (75 kDa) (TNFR-I and -II) (reviewed in reference 68) . LT␣ is coexpressed with the membrane protein LT␤ as LT␣␤ heterodimers, which are tethered to the cell membrane. LT␣ 1 ␤ 2 binds to a TNF family receptor known as LT␤R. LIGHT is a second ligand interacting with the LT␤R. LIGHT also binds to the TNF family receptors herpesvirus entry mediator (HVEM) and decoy receptor 3. Activated lymphocytes and a subset of resting B cells express LT. The LT␤R is expressed mainly on nonhematopoietic and myeloid lineage cells (reviewed in ref- erence 22) . The expression of LT␣␤ and LIGHT is induced by activation of lymphoid cells and certain cytokines and chemokines, including interleukin 4 (IL-4), IL-7, CXC chemokine ligand 13 (CXCL13), and CCL19/CCL21 (22) . While regulation of LT␤R expression remains to be defined, HVEM expression is induced during T-cell activation (22) . LT ligand/LT receptor LIGHT gene-deficient and transgenic mice. The roles of the LT/LIGHT ligands and receptors have been characterized in gene-deficient mice. Gestational and postgestational inhibition of the LT␤R allows us to distinguish between the specific functions of the LT␣␤/LIGHT-LT␤R pathway at different developmental time points. Table 1 summarizes the defects in intestinal lymphoid organ develop-ment observed in mice with disrupted LT␤R-and TNFRmediated signaling.
Deletion of the lt␣ gene in LT␣ Ϫ/Ϫ mice is associated with the loss of all lymph nodes (LNs) and Peyer's patches (PPs) and changes to the lymphoid architecture of the spleen (3, 11) . Targeted disruption of the lt␤ gene results in loss of peripheral LNs, whereas the mucosa draining cervical and mesenteric LNs (MLNs) are retained (29) . LT␤R Ϫ/Ϫ mice have a pheno- On top is shown the interaction between LT␣ 1 ␤ 2 expressed on follicular B cells and LT␤R expressed on FDCs, resulting in secretion of CXCL13, which attracts B cells to the follicle. A CXCL13 gradient is required to maintain the differentiation status of the FDCs. LT␤R engagement is necessary for continued expression of VCAM1 on FDC networks. On the bottom, blocking of LT␤R results in a loss of differentiation of FDCs and presumably cell death and the loss of the CXCL13 chemokine gradient. Thus, the follicle disintegrates.
type very similar to that of LT␣ Ϫ/Ϫ mice (19) . LIGHT, the second ligand of the LT␤R, is predominantly expressed on T cells and serves as a costimulatory molecule (reviewed in reference 66). In contrast to LT␣ Ϫ/Ϫ mice, LIGHT Ϫ/Ϫ mice develop intact lymphoid organs, indicating a predominant role for the LT␣␤-LT␤R interaction in the formation of secondary lymphoid organs (61) . Conversely, transgenic expression of LIGHT in LT␣ Ϫ/Ϫ mice restores splenic T-and B-cell segregation, FDCs, and germinal-center (GC) formation but not marginal-zone (MZ) formation, suggesting that LIGHT can compensate for the loss of certain LT␣␤ functions in the presence of the LT␤R (66) . CD8 ϩ cells from LIGHT Ϫ/Ϫ mice show decreased proliferative responses, while the IL-2 secretion is decreased in CD4 ϩ cells from these mice (61), indicating a role for LIGHT as a costimulatory molecule. Conversely, transgenic expression of LIGHT on T cells is associated with a hyperactivated enlarged T-cell compartment and spontaneous autoimmunity, including inflammatory bowel disease (67) .
Gestational and postgestational inhibition of LT␤R-mediated signaling. Treatment with soluble LT␤R-immunoglobulin G (IgG) fusion protein (LT␤RIgG) similarly blocks the interaction of LT␣␤ and LIGHT with the LT␤R. Therefore, the effects observed in LT␤RIgG-treated animals are a result of the inhibition of both ligands. Gestational treatment with LT␤RIgG prevents the formation of PPs and LNs (56) . Postgestational LT␤R signaling during the first 6 weeks after birth is critical for the development of intestinal lamina propria B cells, IgA secretion, and isolated lymphoid follicles of the intestine (38, 48) .
Mode of action of LT␤R inhibition in adult mice. The lymphoid microenvironment is defined as the local interplay between mobile lymphocytes and the fixed reticular/stromal cells and includes cell adhesion, trafficking, chemokine function, and cellular positioning (22) . Secondary lymphoid organs are structures with a high degree of plasticity. Inhibition of LT␤R signaling in adult mice alters the lymphoid microenvironment. As shown in Fig. 1 , bottom, FDC networks and GCs disintegrate and B-cell follicles disappear in the absence of LT␤R signaling. Figure 2 depicts the lymphoid microarchitecture of a murine wild-type (wt) spleen and describes the changes observed in mice with blocked LT␤R signaling. ϩ B cells to the follicle and is also required to maintain the differentiation status of the recruited B cells and the FDCs in the network. Similarly, LT␤R engagement is required for continued expression of the vascular-cell adhesion molecule 1 (VCAM1) by the FDC network (23, 25) .
The expression of VCAM1 is similarly reduced in FDC networks and splenic MZs following LT␤RIgG treatment. Splenic MZs are located between the red and white pulp of the spleen and consist of a reticular matrix harboring B cells, macrophages, and dendritic cells (DCs). Blood-borne antigen is captured in the MZ and presented to B cells. Marginal zones are critical for immunity against T-cell-independent bacterial antigens (24) . MZ markers disappear following LT␤RIgG treatment.
Inhibition of the LT␤R also blocks the migration or maturation of the cysteine-rich domain of the mannose receptor (CR-Fc)-positive DCs (42, 71) Figure 3 describes three potential mechanisms by which inhibition of the LT␤R alters autoimmunity and host defense.
PPs, isolated lymphoid follicles, cryptopatches, and colonic patches are organized lymphoid aggregates of the intestine. The number and cellular contents of these aggregates are reduced in adult mice undergoing anti-LT␤R treatment (13) .
The potential mode of action in anti-LT␤R treatment is to impair immune function by preventing proper placement of T cells, B cells, and APCs in secondary lymphoid organs, thus preventing the induction of appropriate antigen-specific immune responses. In contrast, selective inhibition of LIGHT signaling results in a loss of LIGHT-mediated costimulatory stimuli. Soluble HVEM-Fc fusion protein selectively blocks LIGHT-HVEM interactions, inhibits CD3-induced T-cell proliferation, and reduces the frequency of spontaneous diabetes in nonobese diabetic mice (67) .
Ectopic "tertiary" lymphoid organs and inflammatory diseases. A number of human inflammatory and autoimmune disorders are associated with the formation of ectopic lymphoid structures at the site of the inflamed organ which resemble secondary lymphoid organs (69; reviewed in reference 60). It is likely that immune responses to self antigens expand in these de novo lymphoid organs, as they allow colocalization of antigen-specific T and B cells with APCs. In mice, ectopic lymphoid structures can be induced by transgenic overexpression of LT␣ (31), and they are called tertiary lymphoid tissues.
Data from animal models of autoimmune diseases associated with the formation of ectopic lymphoid tissue indicate that autoimmunity is less severe, cured, or prevented if the LT␤R is blocked in these conditions (reviewed in reference 22). A potential role for microbial pathogens in the pathogenesis of inflammatory disorders, such as rheumatoid arthritis or inflammatory bowel disease, has been discussed (18) . Granulomas are common histological hallmark of Crohn's disease and mycobacterial infections and serve as sites where T cells, APCs, and antigens collocate (44) . Granulomas resemble tertiary lymphoid tissues. The recruitment of T cells to granulomas was impaired in LT␣ Ϫ/Ϫ (donor) 3 (transfer) wt (recipient) bone marrow chimeras infected with Mycobacterium tuberculosis (58) . It is therefore possible that anti-LT␤R targeted therapy might also shut down common pathways of host defense and inflammatory responses that might lead to autoimmunity in genetically predisposed persons.
Lymphotoxin and LIGHT contribute to central immune tolerance in mice. While a stimulatory role for LT␤R signaling in the induction of peripheral autoimmune disease has been demonstrated by effective treatment of such conditions by anti-LT␤R therapy, the thymic expression of LT␤R and LT␤R ligands contributes to central tolerance. Lymphotoxin signaling is required for the expression of Aire, which is a key mediator of central tolerance for peripherally restricted antigens. Similarly, LT␤R ligand expression on thymic epithelial cells is required for proper differentiation of thymic medullary epithelial cells. LT␣ Ϫ/Ϫ and LT␤R Ϫ/Ϫ mice show infiltration of liver, lung, pancreatic islands, and kidney with activated lymphocytes, and autoantibodies can be detected in these mice (7, 10) . Thus, LT␤R signaling plays different roles in the peripheral and central control of immune tolerance.
THE ROLE OF LT␤R-MEDIATED SIGNALING IN INFECTIOUS DISEASES
Bacterial infections. Both types of animal models predominantly requiring cellular immunity and T-cell-mediated humoral immunity for clearance of bacteria have been investigated. Host defense against intracellular bacteria eliminated by cellular immune mechanisms in mice with disrupted LT␤R-mediated signaling was severely impaired in most studies. The immune response against bacterial pathogens inducing combined T-and B-cell immunity varied in mice with blocked LT␤R activation with the different models tested, suggesting that certain bacterial antigens (Citrobacter rodentium) required LT␤R-mediated signaling while others (Salmonella enterica) were cleared in an LT␤R-independent fashion. (1, 20, 27, 64) , the contribution of soluble LT␣ 3 as the second TNFR-I ligand in antimycobacterial host defense was unknown. Therefore LT␣ Ϫ/Ϫ mice and TNF-␣ and LT␣ double-gene-deficient (TNF/LT␣ Ϫ/Ϫ ) mice were infected with Mycobacterium bovis bacillus Calmette-Guérin (BCG) (8, 26, 51) or Mycobacterium tuberculosis (14) . Studies investigating the role of LT in experimental mycobacterial disease are of clinical relevance considering the reactivation of tuberculosis observed in patients treated with TNF-␣ antagonists (21) . Table 3 summarizes studies investigating bacterial infections in mice with blocked LT␤R signaling. The course of mycobacterial infection was lethal in TNF/LT␣ Ϫ/Ϫ and LT␣ Ϫ/Ϫ mice. Survival was longer in BCG-infected LT␣ Ϫ/Ϫ mice (182 days) and in TNF-␣ Ϫ/Ϫ mice (56 days) than in TNF/LT␣ Ϫ/Ϫ mice (35 days), indicating that the absence of TNF-␣ in this infection leads to broader immunodeficiency than the absence of LT␣. The impaired antimycobacterial immune response in mice without TNF-␣ was aggravated by the simultaneous lack of LT␣ (8) . Similarly, the bacterial loads of the lung on day 28 of the infection were 1,000-, 40-, and 1.4-fold higher in TNF/LT␣ Ϫ/Ϫ , TNF-␣ Ϫ/Ϫ , and LT␣ Ϫ/Ϫ mice than in the respective wt mice. Introduction of an LT␣ transgene in TNF/LT␣ Ϫ/Ϫ mice delayed disease onset but failed to restore resistance to BCG infection, suggesting a transient protective effect exerted by LT␣ in this disease model. Roach et al. generated LT␣ Ϫ/Ϫ 3 wt bone marrow chimeras in order to investigate the role of soluble LT␣ 3 in antimycobacterial immunity (58) . There was lethal disease in wt mice with lymph nodes and LT␣ Ϫ/Ϫ bone marrow, indicating a critical role for soluble LT␣ in antimycobacterial immunity.
The proinflammatory cytokine TNF-␣ is secreted as a soluble TNF-␣ 3 molecule and is also tethered to the cell membrane. Olleros et al. investigated the role of membrane-bound noncleavable TNF-␣ by creating membrane TNF-␣ transgenic mice on the TNF/LT␣ Ϫ/Ϫ background, thus specifically studying the role of membrane TNF-␣ in the absence of soluble TNF-␣ and LT␣. Following inoculation with BCG, the infection was controlled in membrane TNF ϩ/ϩ transgenic TNF/ LT␣ Ϫ/Ϫ mice, though the bacterial load was higher in these 
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Lethal course of infection in all LT ligand/receptor gene-deficient mice with spread of bacteria to liver and spleen; more severe course in LT␤RIgG-treated wt mice mice than in wt animals. Thus, membrane TNF alone is capable of controlling BCG infections (51) . As TNF-␣ Ϫ/Ϫ mice also succumb to BCG infection, the expression of LT␣ in the absence of TNF is not sufficient to control this mycobacterial infection (8) .
Causes for the impaired antimycobacterial immunity in LT␣ and TNF/LT␣ gene-deficient mice varied in the different models studied. The granulomatous responses to BCG infection were similarly delayed and impaired in TNF/LT␣ Ϫ/Ϫ and TNF-␣ Ϫ/Ϫ mice (8, 26) . There were fewer macrophages with reduced inducible nitrite oxide synthase (iNOS) and acid phosphatase expression. Fewer T cells could be detected in these lesions. These observations indicate a central role for TNF in the recruitment of T cells and macrophages to granulomatous lesions, which cannot be compensated for by the presence of LT␣. Conversely, transgenic expression of noncleavable membrane TNF-␣ in TNF/LT␣ Ϫ/Ϫ mice resulted in a two-to fourfold increase in the number of hepatic granulomas, which were of smaller size and predominantly consisted of macrophages (51) .
In LT␣ Ϫ/Ϫ 3 wt bone marrow chimeras infected with M. tuberculosis, there was normal recruitment of T cells to the lungs (58) . However, pulmonary T cells remained in the perivascular and peribronchial areas and failed to collocate with the macrophages in granulomas.
There are controversial findings generated in different systems regarding the role of LT␣ 1 ␤ 2 -LT␤R interaction in the control of mycobacterial infections (14, 39, 58) . Wild-type mice infected with BCG and undergoing LT␤RIgG treatment and LT␤R Ϫ/Ϫ mice infected with M. tuberculosis suffered a more severe course of disease (14, 39) . Similarly, the bacterial loads in livers and lungs of LT␤ Ϫ/Ϫ mice infected with M. tuberculosis were elevated (14) . LT␤R Ϫ/Ϫ 3 wt bone marrow chimeras failed to control M. tuberculosis infection (14) . The impaired immune response against mycobacteria in mice with disrupted LT␤R was associated with decreased iNOS activity in the lung and spleen (14, 39) . In contrast, Roach reported normal clearance of mycobacterial infections in LT␤ Ϫ/Ϫ 3 wt bone marrow chimeras. The reasons for these discrepant observations are unknown and might be related to a different lymphoid microenvironment in LT␤ Ϫ/Ϫ 3 wt and LT␤R Ϫ/Ϫ 3 wt bone marrow chimeras. LIGHT, a second ligand of the LT␤R, is not involved in the control of disease, as LIGHT Ϫ/Ϫ mice cleared M. tuberculosis infections at the same rate as wt mice did (14) .
The course of experimental murine listeriosis was more severe in TNF/LT␣ Ϫ/Ϫ and LT␤R Ϫ/Ϫ mice, suggesting that in addition to TNF-␣, LT␣ and engagement of the LT␤R are critical for control of this intracellular pathogen (27, 53, 59) .
Most studies indicate that interaction of LT␣ 3 -TNFR and of LT␤ with the LT␤R is required for control of infections with the intracellular pathogens Mycobacterium and Listeria. The elimination of these pathogens depends strongly on cellular immunity. Only one study utilized LT␤RIgG in adult mice (39), a situation comparable to human treatment of autoimmune diseases. This study showed a significant but moderate increase in the number of acid-fast bacilli (three-to fourfold) in LT␤RIgG-treated mice compared to 10-to 1,000-fold increases observed in the studies utilizing gene-deficient mice. However, the biological relevance of this observation in terms of disease-related mortality was not investigated in this study, as all mice were sacrificed for in vitro analysis 4 weeks after infection, while most gene-deficient mice used in other studies died after day 30 following mycobacterial infection.
Experimental infectious colitis. (i) Salmonella enterica serovar Typhimurium and Salmonella enterica.
Infection of LT family gene-deficient mice with Salmonella enterica serovar Typhimurium has been utilized to investigate the roles of LT␣ and TNF-␣ in the regulation of anti-Salmonella immunity.
Oral infection of TNF/LT␣ Ϫ/Ϫ mice with S. enterica serovar Typhimurium results in a lethal course of infection compared to mild disease in wt mice. This difference was most likely due to reduced recruitment of neutrophils to the site of infection, as well as reduced intracellular killing of S. enterica serovar Typhimurium by granulocytes (12) .
Mice undergoing oral pretreatment with streptomycin develop infectious colitis, which closely resembles human S. enterica-induced colitis, following oral infection with S. enterica serovar Typhimurium. The development of S. enterica-induced colitis was not affected by the presence of PP, MLN, or the LT␤R, as the courses of the infection in wt and LT␤R Ϫ/Ϫ mice without PP and MLN were similar. Infection of mice with S. enterica without antibiotic treatment induced a typhoid type of disease with bacterial expansion in PP and MLN. Interestingly, the typhoid type of S. enterica infection was also similar in wt and LT␤R Ϫ/Ϫ mice, indicating that while S. enterica might home to intestinal lymphoid organs, PP, MLN, and LT␤R are not required for antibacterial immunity against this invasive pathogen (4).
(ii) Citrobacter rodentium. We have recently investigated the role of LT ␣ 1 ␤ 2 -LT␤R interactions in the course of infectious colitis induced by Citrobacter rodentium (65) . Infection of mice with the gram-negative bacterium C. rodentium serves as an animal model of human infection with enteropathogenic and enterohemorrhagic Escherichia coli (36) . In adult and immunecompetent mice, there is only mild transient colitis with hyperplasia of infected colonic epithelial cells. The course of C. rodentium-induced colitis was more severe in LT␤RIgG-treated mice, with increased disease-related mortality (65) . Similarly, there was nearly 100% disease-related mortality in C. rodentium-infected LT␣ Ϫ/Ϫ , LT␤ Ϫ/Ϫ , and LT␤R Ϫ/Ϫ mice, suggesting a critical role for LT␣ 1 ␤ 2 -LT␤R interactions in antiCitrobacter immunity. In mice with disrupted LT␤R signaling, there were fewer splenic CD11c ϩ dendritic cells following oral infection. FDCs were absent in the spleens of LT␤RIgG-treated mice. Similarly, there were fewer colonic lymphoid follicles in LT␤RIgG-treated mice and in the gene-deficient mice used. In LT␤R Ϫ/Ϫ mice, anti-Citrobacter IgG2a antibody titers were reduced while IgG1 titers were increased. Similarly, there was increased Citrobacter-induced secretion of IL-4 in LT␤R Ϫ/Ϫ mice. These observations indicate that the loss of local intestinal lymphoid organs and changes to antigen-presenting functions of the spleen are associated with impaired immunity against this noninvasive pathogen.
(iii) LPS-induced systemic shock. A number of studies showed resistance of TNF/LT␣ Ϫ/Ϫ mice against lethal endotoxemia induced by intravenous LPS injection (12, 17) , depending on the bacterial origin of the LPS. Eugster described resistance to shock induced by coadministration of D-galactosamine and E. coli-derived LPS (17 (46) . These differences were associated with increased IL-1 and gamma interferon secretion following injection of the lethal S. enterica serovar Typhimurium LPS. BCG-sensitized TNF/LT␣ Ϫ/Ϫ and TNF-␣ Ϫ/Ϫ mice were completely resistant to E. coli LPS-induced shock, whereas LT␣ Ϫ/Ϫ mice showed prolonged survival compared to wt mice (8) . Thus, LT␣ contributes to septic shock, although TNF-␣ appears to be more potent in the induction of LPS shock than LT␣.
Viral infections. A number of studies have investigated the role of LT in viral infections, most of them studying influenza virus, herpesvirus, and lymphocytic choriomeningitis virus infections in gene-deficient mice with anatomical defects. Table  4 summarizes studies of experimental viral infections in mice. Except for two studies (37, 55) , all of them utilized mice with genetic defects of the LT ligands. Similar to LPS-induced shock models, virus-induced systemic shock was less severe in mice with impaired LT␤R, most likely due to a depletion of virus-specific CD8 ϩ T cells following LT␤RIgG treatment. Overall antiviral cytotoxic-T-cell immune responses were more or less impaired, and the clearance of the virus was slowed down or inhibited, leading to a lethal course in influenza A virus (40) , murine cytomegalovirus (MCMV) (5), and Theiler's virus (37) infections. In the extensively studied lymphocytic choriomeningitis virus infection model, the defective antiviral immune response was secondary to the loss of the marginal zone in the spleen (6, 45) but not due to the absence of LT␤ itself. Similarly, treatment of adult wt mice with LT␤RIgG did not affect immunity against Theiler's virus infection, while LT␣ Ϫ/Ϫ and LT␤R Ϫ/Ϫ mice failed to mount appropriate antiviral cytotoxic-T-cell responses (37) , suggesting that changes to splenic and lymph node architecture, but not the presence of LT␤, were critical for clearing of the infection.
Parasite infections. Studies investigating the role of LT in parasite infections are summarized in Table 5 .
(i) Toxoplasma gondii. Schlüter et al. compared the course of experimental toxoplasmosis in wt, TNF-␣ Ϫ/Ϫ , LT␣ Ϫ/Ϫ , and TNF/LT␣ Ϫ/Ϫ mice in order to dissect the roles of both ligands of the TNF receptors in this infection (62) . TNFR-I plays a predominant role in experimental toxoplasmosis. TNF-␣ induces toxoplasmastatic gamma interferon secretion in macrophages and microglial cells in the central nervous system (9, 34) .
All gene-deficient mice tested in this study failed to control (ii) Leishmania. Infection of LT␤ Ϫ/Ϫ mice with Leishmania major was associated with a fatal course of disease with visceral spread of parasites despite the resistant genetic background of the C57BL/6 mice used in this study (70) . The impaired and delayed cellular and humoral anti-L. major immune response in LT␤ Ϫ/Ϫ mice was secondary to changes in the lymphoid architecture. Reconstitution of LT␤ Ϫ/Ϫ mice with wt bone marrow failed to restore effective antiparasite immunity, whereas wt mice receiving LT␤ Ϫ/Ϫ bone marrow were not immunocompromised.
Murine Leishmania donovani infection induces visceral leishmaniasis and is more severe in both TNF-␣ Ϫ/Ϫ and LT␣ Ϫ/Ϫ mice (15) . Experiments with bone marrow radiation chimeras indicated a critical role for liver-generated LT␣ in the migration of leukocytes from periportal to sinusoidal areas, while T-cell-generated TNF-␣ and LT␣ were required for the control of parasite growth.
(iii) Trypanosoma brucei. Infection of LT␣ Ϫ/Ϫ and TNF/ LT␣ Ϫ/Ϫ double-gene-deficient mice with the extracellular parasite Trypanosoma brucei was associated with control of disease and slightly prolonged survival of LT␣ Ϫ/Ϫ mice following infection (43) . Trypanosoma-specific IgM and IgG2a serum antibody titers were increased in LT␣ Ϫ/Ϫ mice, indicating that germinal centers and FDC networks were not required for this antiparasite humoral immune response.
(iv) Cerebral malaria. Infection of mice with Plasmodium berghei serves as an animal model for human cerebral malaria. LT␣ Ϫ/Ϫ mice were protected against cerebral malaria, as they did not develop perivascular cerebral hemorrhage. Bone marrow chimera experiments indicated that a radioresistant cerebral cell population is the source of the LT␣ required for extravasation of malaria-infected erythrocytes (16) .
Prion disease/scrapie. Transmissible spongiform encephalopathies (TSEs), or "prion diseases," are chronic neurodegenerative diseases that affect humans and animals. Most TSEs, including human variant Creutzfeldt-Jakob disease and experimental prion disease in mice, are transmitted by peripheral exposure. TSE infection results in conversion of normal prion protein (PrP c ) to the disease-associated form, PrP sc . Intracerebral or peripheral administration of prions to mice induces a rise of infectivity in the spleen and in other lymphoid organs long before the development of neuropathological changes. (41) .
As FDCs were similarly absent in TNF-␣ Ϫ/Ϫ , TNFR-I Ϫ/Ϫ , and LT␣, LT␤ Ϫ/Ϫ mice but only LT gene-deficient mice were protected against experimental scrapie, FDCs are not required for the replication of scrapie in lymphoid tissue following i.p. infection. More likely, some other yet-undefined effect of impaired LT␤R-mediated signaling is critical for control of the expansion of scrapie protein in lymphoid tissues. The susceptibility of LT␣ Ϫ/Ϫ mice to oral scrapie and the resistance of LT␤ Ϫ/Ϫ mice and LT␤RIgG-pretreated mice to oral infection are two controversial observations which require further investigation.
SUMMARY AND CONCLUSIONS
The studies of experimental infectious diseases summarized in this review reveal the complex biological functions of the LT␣␤/LIGHT-LT␤R pathway in immunity to infectious agents. As the courses of the respective infections were attenuated, unchanged, or even more severe, the role of LT␤R signaling in host defense depends on the respective pathogens. Animal models predominantly requiring cellular immunity or T helper cell-mediated humoral immunity for clearance of the respective infectious agent have been investigated. Overall, the contribution of the LT␤R pathway to host defense against the respective pathogen depended on the antigenic properties of the pathogen, but not on the type of immune response induced by it.
Host defense against bacterial intracellular pathogens such as mycobacteria and Listeria mediated by cellular immune mechanisms in mice with disrupted LT␤R-mediated signaling was severely impaired in most studies. Similarly, in most models of viral infections, cytotoxic-T-cell responses were diminished, although the defect in host defense observed was secondary to changes in lymphoid microarchitecture and not caused by the absence of LT. The elimination of the obligate intracellular parasite Toxoplasma gondii depends on T-cell responses and on the presence of LT␣. Conversely, the clearance of the intracellular parasite Leishmania major depends on T helper 1-mediated cellular immunity and is independent of LT␤R-mediated signaling, while the extracellular parasite Trypanosoma brucei is similarly cleared in LT␣ Ϫ/Ϫ mice and in wild-type mice (43) , indicating that there is no common pattern for LT␤R signaling in the host defense against intracellular or extracellular parasites. The immune responses against bacterial pathogens inducing combined T-and B-cell immunity varied in mice with blocked LT␤R activation with the different models tested, suggesting that certain bacterial antigens (Citrobacter rodentium) required LT␤R mediation while others (Salmonella enterica) were cleared in an LT␤R-independent fashion.
The beneficial effects of anti-LT␤R therapy observed in experimental virus-and LPS-induced shock, cerebral malaria, and prion disease call for further studies of the role of LT␤R signaling in the pathogeneses of similar human disease conditions and suggest that anti-LT␤R therapy might also be a future treatment for these diseases.
Few studies using bone marrow chimeras and soluble antagonist LT␤RIgG fusion protein in wt mice have demonstrated differential roles of secondary lymphoid organs and the cytokines LT␣ 3 and its membrane-bound heterodimers. Thus, soluble LT␣ 3 and the LT␤R play pivotal roles in immunity against mycobacterial infections and C. rodentium-induced colitis. The presence of the LT␤R on bone marrow-derived cells is required to clear these infections in mice. In contrast, LT␣ 1 ␤ 2 / LIGHT-LT␤R interactions are not required to clear experimental L. major infection, while a normal splenic, PP, and LN microenvironment is required to overcome experimental leishmaniasis (70) . Similarly, an intact splenic microenvironment is required for the induction of appropriate antiviral immune responses in the lymphocytic choriomeningitis virus model (6, 45) .
Inhibition of the LT␤R is a future therapeutic concept in treatment of autoimmune diseases (22) . The effects of such treatment are secondary to changes to the lymphoid microenvironment and have also been demonstrated in the spleens of nonhuman primates (23) . Compared to the effects observed in LT gene-deficient mice, changes following short-term LT␤RIgG treatment are moderate (Table 1) . However, longterm treatment with LT␤RIgG in mice also deletes PPs and colonic patches and reduces the number of intestinal DCs (13) .
The treatment of adult mice with anti-LT␤R agents is, considering the substantial differences between human and murine immune systems, a situation comparable to the treatment of humans with anti-LT␤R therapy. Impaired host defense following LT␤RIgG treatment has been observed in the BCG and C. rodentium models, while Theiler's virus infection was not affected by LT␤RIgG treatment (37, 39, 65) . Thus, bearing in mind the different modes of action in experimental murine infections and spontaneous infections of humans, immunity against mycobacterial infections and infectious colitis induced by enteropathogenic and enterohemorrhagic E. coli might be impaired in humans undergoing anti-LT␤R treatment. The immunosuppressive and thus host defense-suppressive effect of anti-LT␤R therapy will probably depend on the dose and duration of such treatments.
Gestational treatment of mice with LT␤RIgG results in permanent changes to the development of lymphoid organs (56) . Similar to other potent immune-modulating therapies, the treatment of pregnant women should be strictly prohibited, and preventive measures, such as the use as of oral contraceptives, should be mandatory in sexually active women undergoing such treatment.
Considering the need for new and effective treatment modalities of human inflammatory and autoimmune diseases, LT␤R blockade might be a potent biological tool which has to be carefully tested in clinical trials, considering the delicate balance between sufficient host defense and the suppression of autoimmunity.
